[{"NetIncomeLoss_1_Q2_USD":-11352000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3487000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":17322734.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":27373165.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":3396000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":1.89,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":34000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":34119000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":10900000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-98802000.0,"Depreciation_2_Q2_USD":300000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":5589000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":137166000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-589000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-295000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":6000.0,"AssetsCurrent_0_Q2_USD":270470000.0,"OperatingLeaseExpense_2_Q2_USD":300000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4272938.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":102000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":229923000.0,"Assets_0_Q2_USD":272814000.0,"ShareBasedCompensation_2_Q2_USD":1731000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.94,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":818822.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":139523000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":3.2,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7570000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.03,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":150000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":1015000.0,"CommonStockValue_0_Q2_USD":4000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":186151000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":634000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":268000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":137539000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":277000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":375000.0,"MarketableSecuritiesCurrent_0_Q2_USD":229923000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":735000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":1735000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":76564000.0,"OtherAssetsCurrent_0_Q2_USD":634000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-20604000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-11327000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":497000.0,"OtherAssetsNoncurrent_0_Q2_USD":89000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":36297000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":330980000.0,"Liabilities_0_Q2_USD":5461000.0,"PaymentsOfStockIssuanceCosts_1_Q2_USD":12858764000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":5.52,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2986000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":1105000.0,"PaymentForContingentConsiderationLiabilityInvestingActivities_1_Q2_USD":277000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2511000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-20604000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-11327000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":40000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":391000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":1335.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.45,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":896000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":47000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":1575606.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":25000.0,"LiabilitiesCurrent_0_Q2_USD":4661000.0,"AccountsPayableCurrent_0_Q2_USD":1265000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4250000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":28000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":75000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":36297000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":24442.0,"PrepaidInsurance_0_Q2_USD":2606000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":72000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2255000.0,"NetIncomeLoss_2_Q2_USD":-20651000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20029000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":174844000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":18708000.0,"MarketableSecurities_0_Q2_USD":229900000.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-20062000.0,"OperatingIncomeLoss_1_Q2_USD":-11057000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":138000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":7.71,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.14,"LiabilitiesAndStockholdersEquity_0_Q2_USD":272814000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1731000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":896000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":4399.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4766000.0,"OperatingExpenses_2_Q2_USD":20062000.0,"OperatingExpenses_1_Q2_USD":11057000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.19,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.41,"ProfitLoss_2_Q2_USD":-20651000.0,"ProfitLoss_1_Q2_USD":-11352000.0,"StockholdersEquity_0_Q2_USD":267353000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":522000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":229889000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-302000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3533831.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":657071.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-63665000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":14473000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":2911000.0,"Ticker":"TALS","CIK":"1827506","name":"TALARIS THERAPEUTICS, INC.","OfficialName":"Talaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"360662650.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]